FoxLogica

⏸️ SHFA: HOLD Signal (6/10) – Financial Results for the 1st Quarter Ended September 30, 2025

⚡ Flash Summary

Shifa International Hospitals Limited’s unaudited financial results for Q1 2026 show improved performance compared to Q1 2025. Revenue increased, leading to higher profit before tax and profit for the period. The earnings per share also rose, indicating better profitability for shareholders. The Board did not recommend a cash dividend. Further analysis is needed to assess the sustainability and drivers of this growth.

Signal: HOLD ⏸️
Strength: 6/10
Sentiment: POSITIVE
Time Horizon: MEDIUM_TERM

📌 Key Takeaways

  • 🚀 Revenue increased by 7.85% from PKR 7,061.37 million to PKR 7,615.51 million.
  • ✨ Other income more than doubled, rising by 139.6% from PKR 44.94 million to PKR 95.87 million.
  • 💰 Operating costs increased by 7.11% from PKR 5,951.54 million to PKR 6,374.52 million.
  • 📉 Finance costs decreased by 14.8% from PKR 98.92 million to PKR 84.28 million.
  • 📉 Expected credit losses increased by 21.5% from PKR 19.89 million to PKR 24.15 million.
  • 👍 Profit before levies and income tax rose by 18.6% from PKR 1,035.97 million to PKR 1,228.42 million.
  • 📈 Income tax expense increased by 19.0% from PKR 407.30 million to PKR 484.84 million.
  • 🎉 Profit for the period increased by 18.3% from PKR 628.68 million to PKR 743.58 million.
  • ⭐ Earnings per share (basic and diluted) increased by 18.2% from PKR 9.95 to PKR 11.76.
  • ❌ No cash dividend was recommended by the Board.
  • Balance sheet analysis shows an increase in total assets from PKR 21,430.98 million to PKR 23,438.71 million.
  • Non-current assets increased significantly from PKR 13,913.72 million to PKR 16,454.21 million, mainly due to higher long-term investments.
  • Current assets decreased slightly from PKR 7,517.26 million to PKR 6,984.50 million.
  • Total liabilities increased from PKR 7,124.36 million to PKR 8,388.51 million.

🎯 Investment Thesis

Based on the improved Q1 performance, a HOLD recommendation is appropriate. While the company shows positive momentum, further analysis is needed to understand the sustainability of this growth and the impact of increased long-term investments. A price target of PKR 130, reflecting a 10x multiple on the annualized EPS, is set with a time horizon of 12 months, pending more comprehensive analysis and future performance data.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Exit mobile version